Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

被引：0
|
作者：
Horneff G. [1 ]
Ruperto N. [1 ]
Brunner H. [2 ]
Quartier P. [3 ]
Constantin T. [1 ]
Alexeeva E. [1 ]
Kone-Paut I. [1 ]
Marzan K. [2 ]
Wulffraat N. [1 ]
Schneider R. [2 ]
Padeh S. [1 ]
Chasnyk V. [1 ]
Wouters C. [1 ]
Deschner J.K. [1 ]
Kallinich T. [1 ]
Lauwerys B. [4 ]
Haddad E. [2 ]
Nasonov E. [1 ]
Trachana M. [1 ]
Vougiouka O. [1 ]
Abrams K. [5 ]
Leon K. [5 ]
Lheritier K. [6 ]
Martini A. [1 ]
Lovell D. [2 ]
机构：
[1] PRINTO-Istituto Gaslini, Genova
[2] PRCSG, Cincinnati, OH
[3] Necker-Enfant Malades Hospital, Paris
[4] Cliniques Universitaires Saint-Luc and Université Catholique de Louvain, Brussels
[5] Novartis Pharmaceuticals Corporation, East Hanover, NJ
[6] Novartis Pharma AG, Basel
来源：
Pediatric Rheumatology | / 13卷 / Suppl 1期
关键词：
Safety Profile; Clinical Remission; Macrophage Activation Syndrome; High Disease Activity; Inactive Disease;
D O I：
10.1186/1546-0096-13-S1-O83
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF CANAKINUMAB IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS WITH AND WITHOUT FEVER
    Ruperto, N.
    Brunner, H.
    Quartier, P.
    Constantin, T.
    Alexeeva, E.
    Kone-Paut, I.
    Marzan, K.
    Wulffraat, N.
    Schneider, R.
    Padeh, S.
    Chasnyk, V.
    Wouters, C.
    Deschner, J. Kummerle
    Kallinich, T.
    Lauwerys, B.
    Haddad, E.
    Nasonov, E.
    Trachana, M.
    Vougiouka, O.
    Abrams, K.
    Leon, K.
    Lheritier, K.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 608 - 608
  • [2] Long-Term Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
    Alexeeva, Ekaterina
    Denisova, Rina
    Dvoryakovskaya, Tatyana
    Isaeva, Ksenia
    Kriulin, Ivan
    Alshevskaya, Alina
    Moskalev, Andrey
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
    Lingzhi Qiu
    Le Ma
    Yifan Xie
    Jing Jin
    Yuting Pan
    Shumin Li
    Zhidan Fan
    Haiguo Yu
    [J]. Pediatric Rheumatology, 22
  • [4] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
    Qiu, Lingzhi
    Ma, Le
    Xie, Yifan
    Jin, Jing
    Pan, Yuting
    Li, Shumin
    Fan, Zhidan
    Yu, Haiguo
    [J]. PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [5] 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
    S Yokota
    T Imagawa
    T Miyamae
    K Kasai
    M Mori
    N Nishimoto
    T Kishimoto
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
  • [6] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
  • [7] Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis: Results from the Phase 3 Extension Study
    Brunner, Hermine I.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [8] Long-Term Safety and Efficacy of Abatacept in Children With Juvenile Idiopathic Arthritis
    Ruperto, Nicolino
    Lovell, Daniel J.
    Quartier, Pierre
    Paz, Eliana
    Rubio-Perez, Nadina
    Silva, Clovis A.
    Abud-Mendoza, Carlos
    Burgos-Vargas, Ruben
    Gerloni, Valeria
    Melo-Gomes, Jose A.
    Saad-Magalhaes, Claudia
    Chavez-Corrales, J.
    Huemer, Christian
    Kivitz, Alan
    Blanco, Francisco J.
    Foeldvari, Ivan
    Hofer, Michael
    Horneff, Gerd
    Huppertz, Hans-Iko
    Job-Deslandre, Chantal
    Loy, Anna
    Minden, Kirsten
    Punaro, Marilynn
    Flores Nunez, Alejandro
    Sigal, Leonard H.
    Block, Alan J.
    Nys, Marleen
    Martini, Alberto
    Giannini, Edward H.
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (06): : 1792 - 1802
  • [9] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
    Alexeeva, E.
    Krekhova, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Shingarova, M.
    Kriulin, I.
    Alshevskaya, A.
    Moskalev, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777
  • [10] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
12345